跳至主要内容
临床试验/NCT01776515
NCT01776515已完成1 期

A Randomized, Double-blind, Active-controlled, Parallel, Multicenter Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Low Back Pain Patients

Daewon Pharmaceutical Co., Ltd.0 个研究点开始时间: 2012年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
主要终点
Changes in '100 mm pain VAS' value from baseline

研究概览

简要总结

The purpose of this study is to evaluate effectness of Tramadol Hydrochloride/Acetaminophen SR Tab. and Tramadol Hydrochloride/Acetaminophen Tab. in patients with low back pain.

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult males/Females aged over 20 years
  • Patient with low back pain who needs analgesic administration
  • Patient with low back pain Who correspond with Class 1, 2 in Quebec Task Force Classification
  • Pain VAS Value over 40 mm
  • Subjects who voluntarily or legal guardian agreed with written consent

排除标准

  • Patients with severe GI tract disorder, liver disease, renal disease, heart disease, hypertension
  • Patients with obvious secondary cause(metastatic cancer, fracture, infectious disease)
  • Patients who had taken back surgery within 24 weeks from the screening point
  • Patients who had taken opioid drug, psychotropic drug within 4 weeks from the screening point
  • Patients who had taken steroid drug(oral, injection) within 4 weeks from the screening point

研究组 & 干预措施

Tramadol hydrochloride/Acetaminophen Tab.

Active Comparator

干预措施: Tramadol hydrochloride/Acetaminophen Tab. (Drug)

Tramadol hydrochloride/Acetaminophen SR Tab.

Experimental

干预措施: Tramadol hydrochloride/Acetaminophen SR Tab. (Drug)

结局指标

主要结局

Changes in '100 mm pain VAS' value from baseline

时间窗: 0, 1, 7, 14, 28 day

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Phase 3 Study of Tramadol... | 临床试验